Evidence map›Paper›PMID 40940592›Full record

ArticleEuropean radiology experimental2025

Deep learning for automated segmentation of central cartilage tumors on MRI.

Salvatore Gitto, Anna Corti, Kirsten van Langevelde, Ana Navas Cañete, Antonino Cincotta, Carmelo Messina, Domenico Albano, Carlotta Vignaga, Laura Ferrari, Luca Mainardi and 2 more

Abstract read
In one paragraph

Article in European radiology experimental, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Salvatore Gitto *Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, Milan, Italy.
Anna Corti *Department of Electronics, Information and Bioengineering (DEIB), Politecnico Di Milano, Milan, Italy.
Kirsten van LangeveldeDepartment of Radiology, Leiden University Medical Center (LUMC), Leiden, Netherlands.
Ana Navas CañeteDepartment of Radiology, Leiden University Medical Center (LUMC), Leiden, Netherlands.
Antonino CincottaIRCCS Istituto Ortopedico Galeazzi, Milan, Italy.
Carmelo MessinaDipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, Milan, Italy.
Domenico AlbanoIRCCS Istituto Ortopedico Galeazzi, Milan, Italy.
Carlotta VignagaDepartment of Electronics, Information and Bioengineering (DEIB), Politecnico Di Milano, Milan, Italy.
Laura FerrariDepartment of Electronics, Information and Bioengineering (DEIB), Politecnico Di Milano, Milan, Italy.
Luca MainardiDepartment of Electronics, Information and Bioengineering (DEIB), Politecnico Di Milano, Milan, Italy.
Valentina D A CorinoDepartment of Electronics, Information and Bioengineering (DEIB), Politecnico Di Milano, Milan, Italy.
Luca Maria SconfienzaDipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, Milan, Italy. io@lucasconfienza.it.ORCID http://orcid.org/0000-0003-0759-8431

Funding

Fondazione AIRC per la Ricerca sul Cancro Investigator Grant
6 · The paper itself

Abstract

backgroundAutomated segmentation methods may potentially increase the reliability and applicability of radiomics in skeletal oncology. Our aim was to propose a deep learning-based method for automated segmentation of atypical cartilaginous tumor (ACT) and grade II chondrosarcoma (CS2) of long bones on magnetic resonance imaging (MRI). MATERIALS AND

methodsThis institutional review board-approved retrospective study included 164 patients with surgically treated and histology-proven cartilaginous tumors at two tertiary bone tumor centers. The first cohort consisted of 99 MRI scans from center 1 (79 ACT, 20 CS2). The second cohort consisted of 65 MRI scans from center 2 (45 ACT, 20 CS2). Supervised Edge-Attention Guidance segmentation Network (SEAGNET) architecture was employed for automated image segmentation on T1-weighted images, using manual segmentations drawn by musculoskeletal radiologists as the ground truth. In the first cohort, a total of 1,037 slices containing the tumor out of 99 patients were split into 70% training, 15% validation, and 15% internal test sets, respectively, and used for model tuning. The second cohort was used for independent external testing.

resultsIn the first cohort, Dice Score (DS) and Intersection over Union (IoU) per patient were 0.782 ± 0.148 and 0.663 ± 0.175, and 0.748 ± 0.191 and 0.630 ± 0.210 in the validation and internal test sets, respectively. DS and IoU per slice were 0.742 ± 0.273 and 0.646 ± 0.266, and 0.752 ± 0.256 and 0.656 ± 0.261 in the validation and internal test sets, respectively. In the independent external test dataset, the model achieved DS of 0.828 ± 0.175 and IoU of 0.706 ± 0.180.

conclusionDeep learning proved excellent for automated segmentation of central cartilage tumors on MRI. RELEVANCE STATEMENT: A deep learning model based on SEAGNET architecture achieved excellent performance for automated segmentation of cartilage tumors of long bones on MRI and may be beneficial, given the increasing detection rate of these lesions in clinical practice. KEY POINTS: Automated segmentation may potentially increase the reliability and applicability of radiomics-based models. A deep learning architecture was proposed for automated segmentation of appendicular cartilage tumors on MRI. Deep learning proved excellent with a mean Dice Score of 0.828 in the external test cohort.

Indexed as

Bone NeoplasmsChondrosarcomaDeep LearningImage Interpretation, Computer-AssistedMagnetic Resonance ImagingAdultAgedFemaleHumansMaleMiddle AgedReproducibility of ResultsRetrospective StudiesChondrosarcomaDeep learningMachine learningMagnetic resonance imagingRadiomics

Identifiers

PMID40940592
PMCPMC12431992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.